Global AI in Blood Pressure Monitoring Market size is valued at USD 942.3 Mn in 2024 and is predicted to reach USD 12,749.2 Mn by the year 2034 at a 12.3% CAGR during the forecast period for 2025-2034.
The healthcare sector could undergo a significant transformation as a result of artificial intelligence, particularly in areas such as vital signs and blood pressure monitoring. Generative AI models offer innovative solutions to overcome these limitations in the new era of continuous, personalised, and data-driven healthcare. One of the most significant ways AI is transforming vital sign monitoring is by facilitating frequent and easy remote data collection.
The market is expanding due to several key factors, including the rising prevalence of cardiovascular and hypertension disorders, the growing demand for continuous and non-invasive monitoring, and the increasing adoption of innovative health devices by consumers. Further driving market expansion are developments in AI and sensor technologies, as well as the integration of these technologies with telehealth and remote patient monitoring platforms. The worldwide rise in the prevalence of cardiovascular diseases (CVDs) and hypertension is a major factor driving the market expansion for AI in blood pressure monitoring.
Additionally, advancements in sensor and AI technology support the growth of the AI in blood pressure monitoring market. The precision and dependability of blood pressure measurement have been greatly improved by developments in machine learning, edge computing, and biosensor downsizing. Furthermore, several significant firms in the industry are engaging in a moderate level of merger and acquisition activity. This is a result of the ambition to improve technological capabilities, consolidate in a rapidly expanding market, and gain a competitive edge in the business.
Competitive Landscape
Some of the Major Key Players in the AI in Blood Pressure Monitoring Market are:
- A&D Company, Limited
- Aktiia SA
- Beurer GmbH
- Binah ai
- Biobeat Technologies
- Biofourmis
- Biospectal SA
- Edwards Lifesciences Corporation (now BD)
- FaceHeart Corporation
- Fourth Frontier Technologies Pvt. Ltd.
- GF Health Products, Inc.
- Healthstats International Pte. Ltd.
- Huawei Technologies Co., Ltd.
- Masimo Corporation
- Microlife Corporation
- Nanowear
- Nihon Kohden Corporation
- Rossmax International Ltd.
- Shen AI
- SOMNOmedics AG
- SunTech Medical, Inc.
- Valencell, INC.
- Withings
- Xplore Health Technologies Pvt. Ltd.
- Other Players
Market Segmentation:
The AI in Blood Pressure Monitoring market is segmented based on device type, delivery mode, technology, application, and end-user. Based on device type, the market is segmented into wearable devices (smartwatches, smart rings, patch sensors, fitness bands), cuffless solutions, and cuff-based device. By delivery mode, the market is segmented into on-device AI, cloud-based AI, and hybrid AI. By technology, the market is segmented into natural language processing (NLP), machine learning algorithms (deep learning, unsupervised, supervised, others) and computer vision techniques. By application, the market is segmented into cardiovascular disease prediction, hypertension management, remote patient monitoring, fitness and wellness, others. By end-user, the market is segmented into hospitals & acute care, clinics & ambulatory care, home care settings/patient (consumers), and others.
Based On The Device Type, The Wearable Devices Segment Is Accounted As A Major Contributor To The AI In Blood Pressure Monitoring Market
The Wearable Devices category is expected to hold a major global market share in 2021. These gadgets provide non-invasive, round-the-clock blood pressure monitoring, allowing patients and medical professionals to track changes in health over time. Wearables that combine AI-driven insights with blood pressure monitoring to identify anomalies and recommend lifestyle modifications are becoming more and more popular among consumers. Furthermore, businesses are now able to incorporate AI algorithms straight into wearable technology due to developments in machine learning and sensor downsizing, allowing for real-time data processing without the need for external systems.
Hospitals & Acute Care Segment To Witness Growth At A Rapid Rate
The hospitals & acute care category had the biggest market share because of its vital role in providing patients with acute and chronic cardiovascular problems with quick, accurate, and advanced care. Acute care facilities and hospitals are among the first to implement AI-enabled monitoring systems, incorporating them into the existing healthcare framework to enhance patient outcomes, reduce human error, and enhance professional judgment. Furthermore, healthcare organisations are utilising artificial intelligence in their facilities to enhance patient care.
In The Region, The North American AI In Blood Pressure Monitoring Market Holds A Significant Revenue Share
The North American AI in Blood Pressure Monitoring market is expected to register the highest market share in revenue in the near future attributed to strong reimbursement systems, the prevalence of heart disease, and the rapid integration of artificial intelligence into digital health systems. Further encouraging wider adoption include consumer health awareness, high disposable income, and the desire for wearable and home-based monitoring gadgets. In addition, the Asia Pacific is projected to grow rapidly in the global AI in Blood Pressure Monitoring market due to a rise in the prevalence of hypertension, increased manufacturing investment, and growing public awareness of health issues. The need for AI in blood pressure monitoring is increasing as the population ages and chronic diseases like diabetes, cancer, and cardiovascular diseases become more common.
AI In Blood Pressure Monitoring Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 942.3 Mn |
|
Revenue Forecast In 2034 |
USD 12,749.2 Mn |
|
Growth Rate CAGR |
CAGR of 30.3% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Form, Product, And Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
A&D Company, Limited, Aktiia SA, Beurer GmbH, Binah ai, Biobeat Technologies, Biofourmis, Biospectal SA, Edwards Lifesciences Corporation (now BD), FaceHeart Corporation, Fourth Frontier Technologies Pvt. Ltd., GF Health Products, Inc., Healthstats International Pte. Ltd., Huawei Technologies Co., Ltd., Masimo Corporation, Microlife Corporation, Nanowear, Nihon Kohden Corporation, Rossmax International Ltd., Shen AI, SOMNOmedics AG, SunTech Medical, Inc., Valencell, INC., Withings, Xplore Health Technologies Pvt. Ltd., Other Players. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
